Klein Pavlis & Peasley Financial’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.05M Buy
51,778
+4,855
+10% +$392K 2.11% 13
2026
Q1
$4.07M Buy
46,923
+2,555
+6% +$245K 2.25% 13
2025
Q4
$4.26M Sell
44,368
-765
-2% -$74.3K 2.51% 10
2025
Q3
$4.3M Buy
45,133
+1,140
+3% +$105K 2.64% 10
2025
Q2
$3.83M Buy
43,993
+5,629
+15% +$477K 2.56% 11
2025
Q1
$3.39M Buy
38,364
+8,433
+28% +$755K 2.44% 14
2024
Q4
$2.39M Buy
29,931
+4,807
+19% +$416K 1.93% 18
2024
Q3
$2.26M Buy
25,124
+9,168
+57% +$771K 1.81% 18
2024
Q2
$1.26M Buy
+15,956
New +$1.31M 1.12% 36

Other funds holding MDT

Klein Pavlis & Peasley Financial's MDT Position: Q2 2026 in Review

Klein Pavlis & Peasley Financial increased its Medtronic (MDT) stake by 10% in Q2 2026, buying an estimated $392K and bringing the position to 51,778 shares worth $4.05M. The position accounts for 2.11% of the portfolio, ranked #13.

Klein Pavlis & Peasley Financial first reported a position in MDT in Q2 2024 and has held it in 9 quarters since. The position peaked at $4.3M in Q3 2025. 858 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Klein Pavlis & Peasley Financial held 51,778 shares of Medtronic worth $4.05M as of Q2 2026.
  • Klein Pavlis & Peasley Financial bought 4,855 Medtronic shares in Q2 2026, an estimated $392K.
  • Medtronic made up 2.11% of Klein Pavlis & Peasley Financial's portfolio in Q2 2026, its #13 holding.
  • Klein Pavlis & Peasley Financial first reported a position in Medtronic in Q2 2024 and has held it in 9 quarters since.
  • Klein Pavlis & Peasley Financial's Medtronic position peaked at $4.3M in Q3 2025.
  • 858 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Klein Pavlis & Peasley Financial's 13F filing for Q2 2026, filed 23 Jul 2026.